Deutsche Bank’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
201,499
+38,686
+24% +$416K ﹤0.01% 1670
2026
Q1
$1.38M Buy
162,813
+24,164
+17% +$264K ﹤0.01% 1995
2025
Q4
$1.57M Buy
138,649
+14,236
+11% +$176K ﹤0.01% 1937
2025
Q3
$1.87M Sell
124,413
-37,573
-23% -$547K ﹤0.01% 1819
2025
Q2
$2.29M Sell
161,986
-2,667
-2% -$47.5K ﹤0.01% 1626
2025
Q1
$3.96M Sell
164,653
-5,120
-3% -$181K ﹤0.01% 1352
2024
Q4
$6.34M Buy
169,773
+33,987
+25% +$1.59M ﹤0.01% 1211
2024
Q3
$6.79M Buy
135,786
+37,971
+39% +$1.48M ﹤0.01% 1156
2024
Q2
$3.4M Buy
97,815
+15,640
+19% +$618K ﹤0.01% 1385
2024
Q1
$4.49M Buy
82,175
+36,297
+79% +$1.8M ﹤0.01% 1315
2023
Q4
$1.96M Buy
45,878
+4,141
+10% +$129K ﹤0.01% 1695
2023
Q3
$1.09M Buy
41,737
+3,276
+9% +$68.1K ﹤0.01% 1670
2023
Q2
$920K Sell
38,461
-18,265
-32% -$314K ﹤0.01% 2041
2023
Q1
$775K Buy
56,726
+15,370
+37% +$245K ﹤0.01% 2246
2022
Q4
$574K Buy
+41,356
New +$584K ﹤0.01% 2368

Other funds holding BHVN

Deutsche Bank's BHVN Position: Q2 2026 in Review

Deutsche Bank increased its Biohaven (BHVN) stake by 24% in Q2 2026, buying an estimated $416K and bringing the position to 201,499 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Deutsche Bank first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.79M in Q3 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Deutsche Bank held 201,499 shares of Biohaven worth $3M as of Q2 2026.
  • Deutsche Bank bought 38,686 Biohaven shares in Q2 2026, an estimated $416K.
  • Biohaven made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1670 holding.
  • Deutsche Bank first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Deutsche Bank's Biohaven position peaked at $6.79M in Q3 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.